Tixel® Skin Resurfacing

 
 

Experience the next generation of skin rejuvenation with Tixel®, a revolutionary treatment designed to renew the skin with less downtime and natural, long-lasting results. Tixel delivers controlled thermal energy to stimulate collagen, refine texture, and improve skin quality without lasers, needles, or radiation.

Tixel is an FDA-cleared thermo-mechanical treatment that uses controlled heat. Unlike lasers or microneedling, Tixel does not rely on light, radiation, or needles and can treat:

  • • Fine lines and wrinkles

    • Uneven texture and rough skin

    • Sun damage and hyperpigmentation

    • Melasma

    • Rosacea and redness-prone skin

    • Acne scars and other types of scarring

    • Stretch marks

    • Enlarged pores (helps reduce pore size)

    • Skin laxity and loose skin

    • Sagging jawline and jowls

    • Crepey skin of the eyelids, neck, and décolletage

    • Dull or lackluster complexion

    • Chronic dry eye symptoms

    • Thinning hair and compromised scalp health

After a personalized consultation, a topical numbing cream is applied when appropriate. During treatment, you’ll feel brief warm pulses with minimal discomfort. Sessions typically last 30–45 minutes depending on the area treated.

Post-treatment redness or swelling is mild and temporary (2-5 days; varies by treated area). Most patients resume daily activities quickly with proper aftercare and sun protection.

Results continue to improve gradually as regeneration occurs, with optimal outcomes seen after completing a recommended series. We recommend 3-4 sessions spaced 4-6 weeks apart for optimal and natural collagen and elastin production.

  • Yes. Tixel is safe for a wide range of skin tones and types.

  • Most patients benefit from a series tailored to their concern and goals.

  • Discomfort is minimal, and numbing is used when appropriate.

  • Downtime is mild and typically limited to a few days.

  • Yes. Tixel pairs well with injectables, regenerative therapies, and advanced skincare.